Codice QR

Review and Meta-analysis on the Impact of the ADRA2A Variant rs1800544 on Methylphenidate Outcomes in Attention-Deficit/Hyperactivity Disorder

Background: Methylphenidate is among the most prescribed medications for treating attention-deficit/hyperactivity disorder (ADHD). However, nearly half of pediatric patients with ADHD do not respond to methylphenidate treatment. Pharmacogenetic testing can aid in identifying patients for whom methyl...

Descrizione completa

Salvato in:
Autori principali: Daniel T. Hain, Talal Al Habbab, Elizabeth S. Cogan, Holly L. Johnson, Rebecca A. Law, David J. Lewis
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2022-04-01
Serie:Biological Psychiatry Global Open Science
Soggetti:
ADHD
ADRA2A
Meta-analysis
Methylphenidate
Pharmacogenetics
Stimulants
Accesso online:http://www.sciencedirect.com/science/article/pii/S2667174321000860
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi